Positive impactCompany
Down 25% in 3 months, but market expert Sumeet Bagadia sees recovery, gains in Fortis - Check target price, stop-loss
Mint 1 hr ago·21 Oct 2026, 8:02 am
Fortis Healthcare has seen its stock price drop by approximately 25% over the last three months, reflecting recent market volatility. Despite this decline, Choice Equity Broking has initiated a 'positional trading' call on the stock, suggesting investors hold the shares for medium-term gains rather than short-term trading.
The brokerage firm has set a target price of ₹892, implying a potential upside from current levels. They have also placed a stop-loss at ₹745 to manage risk. The firm's view is supported by technical analysis, which suggests the stock may find support around the ₹750 mark and could rebound if this level holds.
Investors should keep a close watch on the ₹750 support zone. A break below this level could signal further weakness. Conversely, a sustained move above this support could validate the recovery thesis. As always, investors should evaluate their own risk tolerance before making any investment decisions.
Excerpt from Mint
Choice Equity Broking recommends Fortis Healthcare for positional trading at ₹ 794, with a ₹ 892 target and ₹ 745 stop-loss. It sees potential support near ₹ 750 and a possible technical rebound, though a breakdown below that level would weaken the outlook. Fortis Healthcare shares have suffered a sharp correction…Read the original at Mint
Affected stocks
Bullish1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Fortis Healthcare (FORTIS).
- Category: Company.
- AI reads the tone as positive (potentially bullish) for the stock.
Why it matters
A routine update for Fortis Healthcare. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.
